Show
Sort by
-
The immunophenotypical landscape of patients with primary antibody deficiencies and their asymptomatic first-degree relatives : arguments for a multifactorial aetiology
-
Lipoprotein lipase in chronic lymphocytic leukemia : function and prognostic implications
-
- Journal Article
- A2
- open access
The YPEL5-PPP1CB fusion transcript is detected in different hematological malignancies and in normal samples
-
The long non-coding RNA H19 is regulated by LIN28B
-
Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-κB signalling
-
Latent Transforming growth factor Binding Protein 2 (LTBP2) is related to phenotypic changes suggestive for HFPEF in stable outpatients with coronary artery disease and preserved ejection fraction
-
- Journal Article
- A1
- open access
N-Cadherin in neuroblastoma disease : expression and clinical significance
-
- Journal Article
- A1
- open access
RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia
-
Isolation of disseminated neuroblastoma cells from bone marrow aspirates for pretreatment risk assessment by array comparative genomic hybridization
-
A real-time polymerase chain reaction assay for rapid, sensitive, and specific quantification of the JAK2V617F mutation using a locked nucleic acid-modified oligonucleotide
-
Xanthohumol activates the proapoptotic arm of the unfolded protein response in chronic lymphocytic leukemia
-
Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia
-
Downregulation of miR-449a is essential for the survival of EVI1 positive leukemic cells through modulation of NOTCH1 and BCL2
-
Prognostic markers in chronic lymphocytic leukemia: A comprehensive review
-
Xanthohumol: a new potential proteasome inhibitor that activates the pro-apoptotic arm of the unfolded protein response in B-CLL cells